Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00367094 | Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension | PHASE3 | COMPLETED | 296 | — | — | Jul 1, 2006 | - | Jul 9, 2007 | 1 | China |
| Name | Type | Description |
|---|---|---|
| Benazepril plus hydrochlorothiazide | DRUG | - |
Inclusion Criteria: * Male or female patients, age 18 or older * Given informed consent * Diagnosed as having mild to moderate essential hypertension Exclusion Criteria: * Severe hypertension * Significant preexisting cardiovascular and cerebrovascular disease * Diabetes mellitus type 1 or poorly...